Literature DB >> 15920497

Lasting effects of developmental dexamethasone treatment on neural cell number and size, synaptic activity, and cell signaling: critical periods of vulnerability, dose-effect relationships, regional targets, and sex selectivity.

Marisa L Kreider1, Charlotte A Tate, Mandy M Cousins, Colleen A Oliver, Frederic J Seidler, Theodore A Slotkin.   

Abstract

Glucocorticoids administered to prevent respiratory distress in preterm infants are associated with neurodevelopmental disorders. To evaluate the long-term effects on forebrain development, we treated developing rats with dexamethasone (Dex) at 0.05, 0.2, or 0.8 mg/kg, doses below or spanning the range in clinical use, testing the effects of administration during three different stages: gestational days 17-19, postnatal days 1-3, or postnatal days 7-9. In adulthood, we assessed biomarkers of neural cell number and size, cholinergic presynaptic activity, neurotransmitter receptor expression, and synaptic signaling mediated through adenylyl cyclase (AC), in the cerebral cortex, hippocampus, and striatum. Even at doses that were devoid of lasting effects on somatic growth, Dex elicited deficits in the number and size of neural cells, with the largest effect in the cerebral cortex. Indices of cholinergic synaptic function (choline acetyltransferase, hemicholinium-3 binding) indicated substantial hyperactivity in males, especially in the hippocampus, effectively eliminating the normal sex differences for these parameters. However, the largest effects were seen for cerebrocortical cell signaling mediated by AC, where Dex treatment markedly elevated overall activity while obtunding the function of G-protein-coupled catecholaminergic or cholinergic receptors that stimulate or inhibit AC; uncoupling was noted despite receptor upregulation. Again, the effects on signaling were larger in males and offset the normal sex differences in AC. These results indicate that, during critical developmental periods, Dex administration evokes lasting alterations in neural cell numbers and synaptic function in forebrain regions, even at doses below those used in preterm infants. Neuropsychopharmacology (2006) 31, 12-35. doi:10.1038/sj.npp.1300783; published online 25 May 2005.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 15920497     DOI: 10.1038/sj.npp.1300783

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  28 in total

1.  Prenatal dexamethasone selectively decreases calretinin expression in the adult female lateral amygdala.

Authors:  Damian G Zuloaga; David L Carbone; Robert J Handa
Journal:  Neurosci Lett       Date:  2012-06-02       Impact factor: 3.046

2.  Glucocorticoids exacerbate hypoxia-induced expression of the pro-apoptotic gene Bnip3 in the developing cortex.

Authors:  U S Sandau; R J Handa
Journal:  Neuroscience       Date:  2006-11-15       Impact factor: 3.590

3.  Dexamethasone induces apoptosis in the developing rat amygdala in an age-, region-, and sex-specific manner.

Authors:  D G Zuloaga; D L Carbone; R Hiroi; D L Chong; R J Handa
Journal:  Neuroscience       Date:  2011-10-01       Impact factor: 3.590

4.  Prenatal dexamethasone exposure potentiates diet-induced hepatosteatosis and decreases plasma IGF-I in a sex-specific fashion.

Authors:  David L Carbone; Damian G Zuloaga; Ryoko Hiroi; Chad D Foradori; Marie E Legare; Robert J Handa
Journal:  Endocrinology       Date:  2011-11-08       Impact factor: 4.736

5.  Prenatal dexamethasone augments the neurobehavioral teratology of chlorpyrifos: significance for maternal stress and preterm labor.

Authors:  Edward D Levin; Marty Cauley; Joshua E Johnson; Ellen M Cooper; Heather M Stapleton; P Lee Ferguson; Frederic J Seidler; Theodore A Slotkin
Journal:  Neurotoxicol Teratol       Date:  2013-10-28       Impact factor: 3.763

6.  Prenatal dexamethasone augments the sex-selective developmental neurotoxicity of chlorpyrifos: implications for vulnerability after pharmacotherapy for preterm labor.

Authors:  Theodore A Slotkin; Jennifer Card; Alice Infante; Frederic J Seidler
Journal:  Neurotoxicol Teratol       Date:  2013-02-14       Impact factor: 3.763

7.  Prenatal dexamethasone, as used in preterm labor, worsens the impact of postnatal chlorpyrifos exposure on serotonergic pathways.

Authors:  Theodore A Slotkin; Jennifer Card; Frederic J Seidler
Journal:  Brain Res Bull       Date:  2013-11-23       Impact factor: 4.077

8.  Third Trimester Brain Growth in Preterm Infants Compared With In Utero Healthy Fetuses.

Authors:  Marine Bouyssi-Kobar; Adré J du Plessis; Robert McCarter; Marie Brossard-Racine; Jonathan Murnick; Laura Tinkleman; Richard L Robertson; Catherine Limperopoulos
Journal:  Pediatrics       Date:  2016-11       Impact factor: 7.124

9.  The role of growth retardation in lasting effects of neonatal dexamethasone treatment on hippocampal synaptic function.

Authors:  Yu-Chen Wang; Chiung-Chun Huang; Kuei-Sen Hsu
Journal:  PLoS One       Date:  2010-09-21       Impact factor: 3.240

10.  Exposure to dexamethasone during late gestation causes female-specific decreases in core body temperature and prepro-thyrotropin-releasing hormone expression in the paraventricular nucleus of the hypothalamus in rats.

Authors:  David L Carbone; Damian G Zuloaga; Anthony F Lacagnina; Robert F McGivern; Robert J Handa
Journal:  Physiol Behav       Date:  2012-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.